Clinical Trials
Tiziana begins study of nasally administered Foralumab either alone or in combo with dexamethasone to treat COVID-19 in Brazil
Tiziana Life Sciences, a biotechnology company, announced initiation of a collaborative clinical study investigating nasally administered Foralumab either alone or in combination with orally administered...
News
BERG Creates Collaborative Healthcare Model to Transform the Future of Drug Development
Partners across multiple healthcare divisions join forces to break down siloes to accelerate precision medicine opportunities for COVID-19 and beyond BERG, a clinical-stage biotech that...
Clinical Trials
Mayo Clinic Collaborates with Vocalis Health for Clinical Development of Vocal Biomarkers
Mayo Clinic and Vocalis Health, Inc., a company pioneering AI-based vocal biomarkers for use in healthcare, announced a collaboration to research and develop new voice-based...
Clinical Trials
Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira in Moderate-to-Severe Psoriasis Patients
UCB, a global biopharmaceutical company, announced the detailed results of the head-to-head Phase 3 BE SURE study, which demonstrated that patients treated with investigational IL-17A...
News
EC approves Roches Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
Roche announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable...
News
Novavax expands in Maryland as it gears up for late-stage COVID vaccine trial in the U.S.
Novavax has spent much of 2020 advancing its COVID-19 vaccine candidate through early-stage testing and preparing for manufacturing and distribution. And thanks to the promise...
News
Mumbai’s Sion Hospital to start phase-3 trials of first indigenous Covid vaccine
The Lokmanya Tilak General Hospital, also known as Sion Hospital, will soon start phase-3 clinical trials of India’s indigenous Covid-19 vaccine—COVAXINTM. As many as 1,000...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.